Deerfield Management’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1
| Closed | -$10 | – | 119 |
|
|
2023
Q1 | $10 | Hold |
1
| – | – | ﹤0.01% | 106 |
|
|
2022
Q4 | $10 | Hold |
1
| – | – | ﹤0.01% | 104 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 137 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 138 |
|
|
2022
Q1 | $0 | Buy |
+1
| New | – | ﹤0.01% | 136 |
|
|
2021
Q4 | – | Sell |
-1,000,000
| Closed | -$9.95M | – | 146 |
|
|
2021
Q3 | $9.95M | Hold |
1,000,000
| – | – | 0.19% | 91 |
|
|
2021
Q2 | $10.2M | Hold |
1,000,000
| – | – | 0.18% | 112 |
|
|
2021
Q1 | $10M | Hold |
1,000,000
| – | – | 0.21% | 102 |
|
|
2020
Q4 | $10.7M | Buy |
+1,000,000
| New | +$10.7M | 0.21% | 99 |
|